Clinical Features of Diabetic Kidney Disease (DKD)

Natural History and Staging

Stage-by-Stage Clinical Features

Stage 1 - Glomerular Hyperfiltration (Early, Functional)

• Elevated GFR (may reach 130-160 mL/min) due to glomerular hyperperfusion driven by hyperglycemia, RAAS activation, and SGLT2 upregulation in the proximal tubule
• Renal hypertrophy - kidney enlargement detectable on imaging
• No albuminuria - urine dipstick and routine urinalysis are normal
• No symptoms - entirely asymptomatic
• Begins within the first 5 years of diabetes onset

Stage 2 - Silent Structural Damage

• GFR returns toward normal
• Thickening of the glomerular basement membrane (GBM), mesangial expansion, and glomerular hypertrophy develop on biopsy but are not clinically apparent
• Still normoalbuminuric (UACR < 30 mg/g)
• No overt clinical symptoms
• Duration: approximately 5-10 years from onset

Stage 3 - Moderately Increased Albuminuria (Microalbuminuria)

• UACR 30-299 mg/g (or 30-300 mg/24 h) - not detectable by routine dipstick
• Appears 5-10 years after diabetes onset
• GFR may still be normal or mildly elevated
• Blood pressure begins to rise - often the first detectable clinical sign
• This stage is the key intervention window; regression to normoalbuminuria is possible with treatment
• In type 1 diabetes (T1D), microalbuminuria classically progresses over the next 5-10 years to overt proteinuria; in T2D, regression is more common with effective therapy

Stage 4 - Severely Elevated Albuminuria (Overt Proteinuria / Macroproteinuria)

• UACR ≥ 300 mg/g (equivalent to ≥ 500 mg/day total protein on dipstick)
• Proteinuria can range from 500 mg to as high as 25 g/24 hours
• GFR begins declining - rate of decline varies from 1.8 to 14 mL/min/year depending on treatment and comorbidities
• Hypertension is nearly universal at this stage
• Edema may develop - peripheral pitting edema from nephrotic-range proteinuria with hypoalbuminemia
• Nephrotic syndrome (proteinuria >3.5 g/day, hypoalbuminemia, edema) may develop when glomerulosclerosis is severe
• Azotemia (elevated blood urea nitrogen and creatinine) appears
• Diabetic retinopathy is present in > 90% of T1D patients with overt nephropathy (only ~50-60% in T2D)

Stage 5 - ESKD / Kidney Failure

• GFR < 15 mL/min/1.73 m²
• Features of uraemia: fatigue, nausea, vomiting, anorexia, pruritus, fluid overload
• Proteinuria may paradoxically decrease as GFR falls very low (less glomerular filtrate to lose protein into)
• Patients with DM have worse survival on dialysis than non-diabetics
• Kidney transplantation yields better outcomes than dialysis in eligible patients

Key Clinical Features at Presentation

Urinary Sediment

Atypical Presentations Warranting Kidney Biopsy

• Frank hematuria with negative urological workup
• Rapid or accelerated decline in GFR
• Nephrotic-range albuminuria with normal GFR
• Absence of retinopathy in T1D with proteinuria
• Duration of T1D < 5 years with proteinuria
• Serological or clinical features suggesting a non-diabetic cause

Pathological Correlates of Clinical Stages

1. Glomerular basement membrane thickening - detectable by electron microscopy before clinical change; the earliest structural lesion
2. Diffuse mesangial sclerosis - present in most patients after >10 years; causes nephrotic syndrome when severe; associated with hypertension
3. Nodular glomerulosclerosis (Kimmelstiel-Wilson nodules) - ball-like deposits of laminated matrix in the glomerular periphery; found in 15-30% of long-term diabetics; virtually pathognomonic of DM; strongly correlates with retinopathy
4. Hyaline arteriolosclerosis - uniquely affects both afferent and efferent arterioles in DM (efferent involvement is almost unique to diabetes); contributes to glomerular hypertension
5. Nephrosclerosis - diffuse cortical scarring from ischemia; manifests as a finely granular cortical surface
6. Pyelonephritis - more severe in diabetics; necrotizing papillitis (papillary necrosis) is more prevalent in diabetes

Important Clinical Considerations

• Normoalbuminuric DKD: Up to 24% of T1D and 50% of T2D patients with CKD are normoalbuminuric - albuminuria is not universally required for diagnosis
• Cardiovascular risk: Albuminuria and decreased GFR are independent and potent risk factors for CV death - many patients die of CV events before reaching ESKD
• T2D asymmetry: In T2D, many patients have small kidneys and low GFR without significant albuminuria, possibly from macrovascular disease; atherosclerotic renal artery stenosis must be excluded
• Screening: T1D - screen 5 years after diagnosis; T2D - screen at diagnosis; both annually thereafter with spot UACR and eGFR